{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:46:42Z","timestamp":1791352002931,"version":"4.3.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2008,4,23]],"date-time":"2008-04-23T00:00:00Z","timestamp":1208908800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001981","type":"journal-article","created":{"date-parts":[[2008,4,22]],"date-time":"2008-04-22T22:30:21Z","timestamp":1208903421000},"page":"e1981","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":111,"title":["Antihypertensive Drug Guanabenz Is Active In Vivo against both Yeast and Mammalian Prions"],"prefix":"10.1371","volume":"3","author":[{"given":"D\u00e9borah","family":"Tribouillard-Tanvier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"B\u00e9ringue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Desban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Gug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Voisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Galons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Laude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Vilette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Blondel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,4,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/brain\/awl150","article-title":"A systematic review of prion therapeutics in experimental models.","volume":"129","author":"CR Trevitt","year":"2006","journal-title":"Brain"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.1090187","article-title":"Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.","volume":"302","author":"G Mallucci","year":"2003","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2007.01.005","article-title":"Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice.","volume":"53","author":"GR Mallucci","year":"2007","journal-title":"Neuron"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1093\/emboj\/18.12.3193","article-title":"Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.","volume":"18","author":"M Horiuchi","year":"1999","journal-title":"Embo J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.1073\/pnas.85.18.6617","article-title":"Immunoaffinity purification and neutralization of scrapie prion infectivity.","volume":"85","author":"R Gabizon","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jmb.2007.05.052","article-title":"Peptide aptamers expressed in the secretory pathway interfere with cellular PrPSc formation.","volume":"371","author":"S Gilch","year":"2007","journal-title":"J Mol Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"14529","DOI":"10.1073\/pnas.96.25.14529","article-title":"Elimination of prions by branched polyamines and implications for therapeutics.","volume":"96","author":"S Supattapone","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(99)11419-3","article-title":"Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides.","volume":"355","author":"C Soto","year":"2000","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1074\/jbc.M312262200","article-title":"Modulation of prion protein oligomerization, aggregation, and beta-sheet conversion by 4,4\u2032-dianilino-1,1\u2032-binaphthyl-5,5\u2032-sulfonate (bis-ANS).","volume":"279","author":"Y Cordeiro","year":"2004","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1128\/JVI.79.12.7785-7791.2005","article-title":"Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets.","volume":"79","author":"U Bertsch","year":"2005","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/JVI.74.10.4894-4897.2000","article-title":"Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.","volume":"74","author":"K Doh-Ura","year":"2000","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.161274798","article-title":"Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.","volume":"98","author":"C Korth","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1073\/pnas.061337998","article-title":"Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein.","volume":"98","author":"D Vilette","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/JVI.78.1.482-490.2004","article-title":"Cultured peripheral neuroglial cells are highly permissive to sheep prion infection.","volume":"78","author":"F Archer","year":"2004","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1051\/vetres:2007049","article-title":"Cell models of prion infection.","volume":"39","author":"D Vilette","year":"2008","journal-title":"Vet Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/nbt855","article-title":"Isolation of drugs active against mammalian prions using a yeast-based screening assay.","volume":"21","author":"S Bach","year":"2003","journal-title":"Nat Biotechnol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ymeth.2006.04.005","article-title":"A yeast-based assay to isolate drugs active against mammalian prions.","volume":"39","author":"S Bach","year":"2006","journal-title":"Methods"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1126\/science.7909170","article-title":"[<italic>URE3<\/italic>] as an altered Ure2 protein: evidence for a prion analog in <italic>Saccharomyces cerevisiae<\/italic>.","volume":"264","author":"RB Wickner","year":"1994","journal-title":"Science"},{"key":"ref19","article-title":"Prion proteins as genetic material in fungi.","author":"L Benkemoun","year":"2006","journal-title":"Fungal Genet Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/biot.200500001","article-title":"Using budding yeast to screen for anti-prion drugs.","volume":"1","author":"D Tribouillard","year":"2006","journal-title":"Biotechnol J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/jm030480f","article-title":"Selective optimization of side activities: another way for drug discovery.","volume":"47","author":"CG Wermuth","year":"2004","journal-title":"J Med Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0140-6736(89)90510-2","article-title":"Tacrine in Alzheimer&apos;s disease.","volume":"2","author":"R Levy","year":"1989","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2165\/00003495-198326030-00003","article-title":"Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.","volume":"26","author":"B Holmes","year":"1983","journal-title":"Drugs"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1128\/JVI.75.13.5977-5984.2001","article-title":"Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine prp.","volume":"75","author":"JL Vilotte","year":"2001","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ana.10336","article-title":"Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model.","volume":"52","author":"SJ Collins","year":"2002","journal-title":"Ann Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1128\/JVI.77.15.8462-8469.2003","article-title":"Evaluation of quinacrine treatment for prion diseases.","volume":"77","author":"A Barret","year":"2003","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1126\/science.276.5315.1119","article-title":"Effectiveness of anthracycline against experimental prion disease in Syrian hamsters.","volume":"276","author":"F Tagliavini","year":"1997","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1073\/pnas.162195499","article-title":"Tetracyclines affect prion infectivity.","volume":"99","author":"G Forloni","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1128\/JVI.74.12.5432-5440.2000","article-title":"Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent.","volume":"74","author":"V Beringue","year":"2000","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00007611-198206000-00022","article-title":"Clonidine hydrochloride.","volume":"75","author":"MC Houston","year":"1982","journal-title":"South Med J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1099\/0022-1317-65-8-1325","article-title":"Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen.","volume":"65 (Pt 8)","author":"B Ehlers","year":"1984","journal-title":"J Gen Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"9537","DOI":"10.1523\/JNEUROSCI.1942-07.2007","article-title":"Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.","volume":"27","author":"S Dirikoc","year":"2007","journal-title":"J Neurosci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1073\/pnas.91.21.9936","article-title":"Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein.","volume":"91","author":"GC Telling","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0092-8674(95)90236-8","article-title":"Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.","volume":"83","author":"GC Telling","year":"1995","journal-title":"Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1073\/pnas.2627989100","article-title":"Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene.","volume":"100","author":"C Korth","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/S0002-9440(10)63613-9","article-title":"Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions.","volume":"163","author":"Y Taguchi","year":"2003","journal-title":"Am J Pathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1749-6632.1995.tb32460.x","article-title":"Why imidazoline receptor modulator in the treatment of hypertension?","volume":"763","author":"SG Schafer","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1524-6175.2007.07161.x","article-title":"Centrally acting antihypertensive agents: an update.","volume":"9","author":"DA Sica","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"13794","DOI":"10.1128\/JVI.01502-07","article-title":"Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures.","volume":"81","author":"S Cronier","year":"2007","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"11247","DOI":"10.1074\/jbc.M407006200","article-title":"Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells.","volume":"280","author":"C Feraudet","year":"2005","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"16031","DOI":"10.1073\/pnas.0502296102","article-title":"A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes.","volume":"102","author":"A Le Dur","year":"2005","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001981","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:29:11Z","timestamp":1588991351000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001981"}},"subtitle":[],"editor":[{"given":"Floyd","family":"Romesberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,4,23]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,4,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001981","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,23]]}}}